Evidence map›Paper›PMID 31734999›Full record

ReviewZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2019

[Research progress of lipolipomics in primary hepatocellular carcinoma].

X J Shi, Q Q Zheng, J Q Niu, G Y Lyu, X K Liu, G Y Wang

Open access · greenAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. [Research progress of long-chain non-coding RNA in lipid metabolism reprogramming in primary hepatocellular carcinoma].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2024
    Article
  2. [Blood lipid metabolic profile of overweight/obese boys aged 9-12 years].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

X J ShiHepatobiliary Pancreatic Department, The First Hospital of Jilin University, Changchun 130021, China.
Q Q ZhengDepartment of Pathophysiology, China Medical University, Shenyang 110122, China.
J Q NiuHepatobiliary Pancreatic Department, The First Hospital of Jilin University, Changchun 130021, China.
G Y LyuHepatobiliary Pancreatic Department, The First Hospital of Jilin University, Changchun 130021, China.
X K LiuHepatobiliary Pancreatic Department, The First Hospital of Jilin University, Changchun 130021, China.
G Y WangHepatobiliary Pancreatic Department, The First Hospital of Jilin University, Changchun 130021, China.
Jilin University · CNChina Medical University · CN

Funding

Project of Science and Technology Agency, Jilin Province 20180520129JH
6 · The paper itself

Abstract

Presently, nonalcoholic fatty liver disease has become the most common pathogenic factor of chronic liver disease worldwide that can lead to the occurrence of hepatocellular carcinoma (HCC). Lipid metabolism in cancer cells is closely related to tumorgenesis, invasion and metastasis, and thus acts as one of the hallmark of cancer cells. Lipolipomics is an important branch of metabolomics, which has been adapted recently in the study of HCC for analysis of the structure and function of lipid components by chromatography and mass spectrometry. Fatty acids, glycerides, glycerophospholipids, sphingolipids, and sterol are significantly different in HCC tissues or serum. Therefore, it contributes to the diagnosis, determination of prognosis, mechanistic study and targeted therapy of HCC.

Indexed as

MetabolomicsCarcinoma, HepatocellularHumansLipidsLiver NeoplasmsMass SpectrometryNon-alcoholic Fatty Liver DiseaseLipidsHepatocellular carcinomaLipidomicsNonalcoholic fatty liver disease

Identifiers

PMID31734999
PMCPMC12769432
OpenAlexW2988492355

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.